Onderneming Spring Pharmaceutical Group, Inc.
Aandelen
BYC
US84987P1057
Farmaceutische producten
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Chuan Min Li
DFI | Director of Finance/CFO | 59 | 01-01-05 |
Qiang Zhang
ADM | Chief Administrative Officer | 52 | - |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Xu Zhong Ding
SAM | Sales & Marketing | 52 | 01-01-03 |
Ze Cheng Shao
PRN | Corporate Officer/Principal | 51 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Director/Board Member | 73 | 06-04-09 | |
Wen Gao Zhang
BRD | Director/Board Member | 79 | 06-04-09 |
Dong Li
BRD | Director/Board Member | 35 | 01-04-17 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 0 | 45 | 0 | 0 | 61,81 % |
Aandeel B | 1 | 29 839 168 | 18 444 602 ( 61,81 %) | 0 |
Bedrijfsgegevens
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
+51,63% | 796 mld. | |
+41,51% | 628 mld. | |
-5,10% | 358 mld. | |
+19,90% | 331 mld. | |
+9,95% | 301 mld. | |
+17,66% | 244 mld. | |
+3,39% | 228 mld. | |
+10,75% | 214 mld. | |
+6,99% | 165 mld. |